AU5417979A - Isoquinoline derivatives and their use as anti-inflammatory and analgesic agents - Google Patents

Isoquinoline derivatives and their use as anti-inflammatory and analgesic agents

Info

Publication number
AU5417979A
AU5417979A AU54179/79A AU5417979A AU5417979A AU 5417979 A AU5417979 A AU 5417979A AU 54179/79 A AU54179/79 A AU 54179/79A AU 5417979 A AU5417979 A AU 5417979A AU 5417979 A AU5417979 A AU 5417979A
Authority
AU
Australia
Prior art keywords
group
compound
formula
acid
multiplet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54179/79A
Other languages
English (en)
Inventor
Satoshi Funakoshi
Yukio Hasegawa
Takashi Mikami
Nobuyoshi Minami
Katsuhiko Miyasaka
Michitaka Satoh
Yasushi Suzuki
Kunio Tsukamoto
Norio Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
Original Assignee
Teikoku Hormone Manufacturing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Hormone Manufacturing Co Ltd filed Critical Teikoku Hormone Manufacturing Co Ltd
Publication of AU5417979A publication Critical patent/AU5417979A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AU54179/79A 1978-12-27 1979-12-24 Isoquinoline derivatives and their use as anti-inflammatory and analgesic agents Abandoned AU5417979A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16002678 1978-12-27
JP16002678A JPS5587771A (en) 1978-12-27 1978-12-27 1-phenylisoquinoline derivative

Publications (1)

Publication Number Publication Date
AU5417979A true AU5417979A (en) 1980-07-03

Family

ID=15706350

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54179/79A Abandoned AU5417979A (en) 1978-12-27 1979-12-24 Isoquinoline derivatives and their use as anti-inflammatory and analgesic agents

Country Status (4)

Country Link
US (1) US4337256A (enExample)
EP (1) EP0013411A1 (enExample)
JP (1) JPS5587771A (enExample)
AU (1) AU5417979A (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57203068A (en) * 1981-06-08 1982-12-13 Teikoku Hormone Mfg Co Ltd Novel 1-phenylisoquinoline derivative
DE3206660A1 (de) * 1982-02-25 1983-09-01 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von o-acylamidomethylbenzyl-halogeniden
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
US4518779A (en) * 1982-09-27 1985-05-21 Pennwalt Corporation 1,2,3,4-Tetrahydro-1-aminomethyl-4-phenyl isoquinolines
KR930703259A (ko) * 1990-12-17 1993-11-29 알베르투스 빌헬무스 요아네스 쩨스트라텐 살균성 이소퀴놀린 유도체
DE60325834D1 (de) * 2002-02-20 2009-03-05 Abbott Lab Kondensierte azabicyclischeverbindungen als inhibitoren des vanilloid-rezeptors 1 (vr1)
US6933311B2 (en) * 2003-02-11 2005-08-23 Abbott Laboratories Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
CA2661898A1 (en) 2006-08-25 2008-02-28 Abbott Laboratories Indazole derivatives that inhibit trpv1 and uses thereof
EP2526948A1 (en) 2006-09-20 2012-11-28 Aerie Pharmaceuticals, Inc. RHO kinase inhibitors
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
WO2010126626A2 (en) 2009-05-01 2010-11-04 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
ES2776199T3 (es) 2013-03-15 2020-07-29 Aerie Pharmaceuticals Inc Conjugados de compuestos de isoquinolina y prostaglandinas
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
WO2017086941A1 (en) 2015-11-17 2017-05-26 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
WO2018045091A1 (en) 2016-08-31 2018-03-08 Aerie Pharmaceuticals, Inc. Ophthalmic compositions
CA3057872A1 (en) 2017-03-31 2018-10-04 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
AU2019337703B2 (en) 2018-09-14 2023-02-02 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
CN117466729A (zh) * 2023-12-28 2024-01-30 山东国邦药业有限公司 一种2,4,5-三氟苯乙酸的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991061A (en) * 1975-07-16 1976-11-09 G. D. Searle & Co. Azanaphthaleneacetic acid derivatives
HU174697B (hu) * 1976-12-30 1980-03-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 6,7-dimetoksi-1,2,3,4-tetragidro-1-izokinolin-acetamida
JPS53101382A (en) * 1977-02-14 1978-09-04 Teijin Ltd Tetrahydroisoquinoline-3-acetic acids and process for their preparation

Also Published As

Publication number Publication date
JPS633857B2 (enExample) 1988-01-26
US4337256A (en) 1982-06-29
JPS5587771A (en) 1980-07-02
EP0013411A1 (en) 1980-07-23

Similar Documents

Publication Publication Date Title
AU521524B2 (en) Quinazoline derivatives
AU528648B2 (en) Quinoline and quinazole derivatives
ZA797008B (en) Anti-inflammatory pharmaceutical composition
AU516238B2 (en) Imidazole-carboxylic acids and their derivatives thereof
AU4890579A (en) Non-steroidal anti-inflammatory agents
ZA794124B (en) Anti-inflammatory agents including 2-carbonyl-3-hydroxy-2-alkenonitriles
AU523043B2 (en) Alpha-azolyl-keto derivatives and their use as fungicides
AU526681B2 (en) Novel isoquinoline derivatives and their preparation
AU5528380A (en) Tricyclic pyrazole derivatives and their use as anti- inflammatory agents
AU512947B2 (en) Quinazoline derivatives
ZA777422B (en) Analgesic and anti-inflammatory composition for topical application
AU534304B2 (en) Anthranilamide derivatives and their use as analgesics,anti- inflammatory and/or anti-allergic agents
AU4621979A (en) Isoquinoline derivatives
AU509372B2 (en) 2-Phenyl-3-Aroylbenzothiophane Derivatives and their use as Antifertility Agents
JPS54141747A (en) Anthranilic acid derivative and its use
AU531086B2 (en) Benzimidazole and benzimidazolidine derivatives
AU534771B2 (en) Analgesic
AU532934B2 (en) 0-chloro-2-benzoyl-4-chloroglycycl anilide derivatives
AU529821B2 (en) Sulfamphthalein and sulfamnaphthalein derivatives
AU518489B2 (en) Thio-indazole derivatives and their use as antiinflammatory agents
NZ190665A (en) S-benzylcysteine derivatives and pharmaceutical compositions
NZ190007A (en) Steroid-spiro-oxazolidinone derivatives and pharmaceutical compositions
AU518324B2 (en) Therapeutically useful cysteinol and homocysteinol derivatives
AU538065B2 (en) Isoquinoline derivatives
GB2012798B (en) Phthalone derivatives their preparation and use